Balaglitazone
Balaglitazone is a selective partial agonist of the peroxisome proliferator-activated receptor gamma (PPARγ) with an EC50 of 1.351 μM. It is utilized in diabetes research as an adjunct to insulin therapy for glucose regulation and has been investigated in preclinical models of cardiovascular conditions, including heart failure and myocardial infarction.
Product Specifications
CAS Number
199113-98-9
Product Name Alternative
PPARγ, human PPARγ, NN2344, NN-2344, NN 2344, Balaglitazone, DRF 2593, DRF2593, DRF-2593
Field of Research
Metabolism Research, Molecular Biology
Purity
99.74% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.35 mM) ; DMSO:80 mg/mL (202.31 mM)
Smiles
Cn1c (COc2ccc (CC3SC (=O) NC3=O) cc2) nc2ccccc2c1=O
Molecular Formula
C20H17N3O4S
Molecular Weight
395.43
Storage Conditions
Store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NCAPG, NT (NCAPG, CAPG, NYMEL3, Condensin complex subunit 3, Chromosome-associated protein G, Condensin subunit CAP-G, Melanoma antigen NY-MEL-3, Non-SMC condensin I complex subunit G, XCAP-G homolog)
Carbohydrate Sulfotransferase 5/CHST5 Recombinant Protein Antigen